Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population

Robert Stein,Andreas Makris,Iain R. Macpherson,Luke Hughes-Davies,Andrea Marshall,Georgina Dotchin,David Cameron,Belinda E. Kiely,Janice Tsang,Bjørn Naume,Daniel Rea,Hege O. Ohnstad,Peter Hall,Stuart McIntosh,Bethany Shinkins,Christopher McCabe,Adrienne Morgan,John M. S. Bartlett,Janet A. Dunn

Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population

2021

Robert Stein
Andreas Makris
Iain R. Macpherson
Luke Hughes-Davies
Andrea Marshall
Georgina Dotchin
David Cameron
Belinda E. Kiely
Janice Tsang
Bjørn Naume
Daniel Rea
Hege O. Ohnstad
Peter Hall
Stuart McIntosh
Bethany Shinkins
Christopher McCabe
Adrienne Morgan
John M. S. Bartlett
Janet A. Dunn

TPS599Background: Multi-parameter tumor gene expression assays (MPAs) are validated tools to assist adjuvant chemotherapy decisions for post-menopausal women with luminal-type node-negative breast ...

Keywords:

Gene expression
Medicine
adjuvant chemotherapy
Internal medicine
Chemotherapy
multi parameter
Population
Oncology
Randomized controlled trial
early breast cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations